Xylem Inc (NYSE: XYL) established initial surge of 3.37% at $144.81, as the Stock market unbolted on Thursday, before settling in for the price of $140.09 at the close. Taking a more long-term approach, XYL posted a 52-week range of $100.47-$154.27.
It was noted that the giant of the Industrials sector posted annual sales growth of 10.55% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 10.55%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 18.56%. This publicly-traded company’s shares outstanding now amounts to $243.50 million, simultaneously with a float of $242.83 million. The organization now has a market capitalization sitting at $35.26 billion.
Xylem Inc (XYL) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Xylem Inc industry. Xylem Inc’s current insider ownership accounts for 0.26%, in contrast to 93.52% institutional ownership. According to the most recent insider trade that took place on Nov 04 ’25, this organization’s Director sold 1,700 shares at the rate of 148.14, making the entire transaction reach 251,838 in total value, affecting insider ownership by 16,875.
Xylem Inc (XYL) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.16 per share during the current fiscal year.
Xylem Inc’s EPS increase for this current 12-month fiscal period is 18.56% and is forecasted to reach 5.58 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 13.08% through the next 5 years, which can be compared against the 10.55% growth it accomplished over the previous five years trading on the market.
Xylem Inc (NYSE: XYL) Trading Performance Indicators
Let’s observe the current performance indicators for Xylem Inc (XYL). It’s Quick Ratio in the last reported quarter now stands at 1.50. Alongside those numbers, its PE Ratio stands at $37.25, and its Beta score is 1.16. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.96. Similarly, its price to free cash flow for trailing twelve months is now 38.12.
In the same vein, XYL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 3.89, a figure that is expected to reach 1.41 in the next quarter, and analysts are predicting that it will be 5.58 at the market close of one year from today.
